Th1 Cytokine-Secreting Recombinant Mycobacterium bovis Bacillus Calmette-Guérin and Prospective Use in Immunotherapy of Bladder Cancer

Intravesical instillation of Mycobacterium bovis bacillus Calmette-Guérin (BCG) has been used for treating bladder cancer for 3 decades. However, BCG therapy is ineffective in approximately 30–40% of cases. Since evidence supports the T helper type 1 (Th1) response to be essential in BCG-induced tum...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Yi, Henning, Jonathan, O'Donnell, Michael A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3173967/
https://www.ncbi.nlm.nih.gov/pubmed/21941579
http://dx.doi.org/10.1155/2011/728930

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3173967/
https://www.ncbi.nlm.nih.gov/pubmed/21941579
http://dx.doi.org/10.1155/2011/728930

Ejemplares similares